Utah Medical Products closed at $70.02 on Nov 3, down 0.75%, 8.7% below its 52-week closing high. Volume of 29.6K shares was 0.70× its 20-day average (below normal).
Split-adjusted performance: -4.5% over one month, +8.0% over six months, +20.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $8.53M, down 14.3% from a year earlier, with a net margin of 31.5%.
Short interest was 140.2K shares at the Oct 15 settlement, down 7.7% from the prior report (4.7% of float, 3.6 days to cover).